Cargando…
Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways
Although trisomy 12 (+12) chronic lymphocytic leukemia (CLL) comprises about 20% of cases, relatively little is known about its pathophysiology. These cases often demonstrate atypical morphological and immunophenotypic features, high proliferative rates, unmutated immunoglobulin heavy chain variable...
Autores principales: | Abruzzo, Lynne V., Herling, Carmen D., Calin, George A., Oakes, Christopher, Barron, Lynn L., Banks, Haley E., Katju, Vikram, Keating, Michael J., Coombes, Kevin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269288/ https://www.ncbi.nlm.nih.gov/pubmed/29976738 http://dx.doi.org/10.3324/haematol.2018.190132 |
Ejemplares similares
-
Unsupervised machine learning and prognostic factors of survival in chronic lymphocytic leukemia
por: Coombes, Caitlin E, et al.
Publicado: (2020) -
A Two-Gene Signature, SKI and SLAMF1, Predicts Time-to-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia
por: Schweighofer, Carmen D., et al.
Publicado: (2011) -
Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review
por: Autore, Francesco, et al.
Publicado: (2018) -
Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression
por: Admirand, Joan H., et al.
Publicado: (2010) -
An unusual case of chronic lymphocytic leukemia with trisomy 12 and t(14;18) and a favorable response to ibrutinib
por: Haddad, Fady Gh, et al.
Publicado: (2021)